3E05302
Introduction Peripheral Artery to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | 5 Peripheral Artery |
| Approach | 3 Percutaneous |
| Device | 0 Antineoplastic |
| Qualifier | 2 High-dose Interleukin-2 |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Peripheral Artery
A peripheral artery, such as the radial or femoral artery, may be accessed to introduce substances directly into the arterial circulation, including diagnostic contrast for angiography or, less commonly, medications intended for localized regional effect. Arterial introduction differs fundamentally from venous administration because the substance enters at high pressure and travels directly to the capillary beds of downstream tissue without first passing through the pulmonary circulation, which can concentrate effects in a targeted vascular territory. This route requires careful technique given the higher pressure and bleeding risk associated with arterial puncture compared with venous access. Documentation should specify the substance introduced and confirm arterial rather than venous placement, since the two routes carry distinct clinical purposes, risks, and coding implications.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Antineoplastic
Antineoplastic designates administration of a substance intended to destroy or inhibit malignant cells, encompassing chemotherapy agents given systemically or regionally as part of cancer treatment. It is distinguished from Destructive Agent, which ablates tissue by direct chemical or physical action rather than targeted cytotoxic pharmacology, and from Radioactive Substance, which achieves its effect through ionizing radiation rather than chemical action.
Qualifier: High-dose Interleukin-2
Specifies that interleukin-2 was administered at a high, intensive dosage regimen, historically used in aggressive immunotherapy protocols for certain metastatic cancers such as melanoma or renal cell carcinoma. This qualifier is distinguished from Low-dose Interleukin-2 purely by dosing intensity, since the two regimens carry different toxicity profiles and clinical indications despite using the same drug.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.